Literature DB >> 17614845

Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis.

Sevgi Bozova1, Gülsüm Ozlem Elpek.   

Abstract

Angiogenesis progresses together with fibrogenesis during chronic liver injury. Hypoxia-inducible factor-1alpha (HIF-1alpha), a master regulator of homeostasis, plays a pivotal role in hypoxia-induced angiogenesis through its regulation of vascular endothelial growth factor (VEGF). The association between hypoxia, angiogenesis and VEGF expression has been demonstrated in experimental cirrhosis. However, expression of HIF-1alpha has yet to be reported. The aim of this study was to investigate the significance of HIF-1alpha expression during experimental liver fibrosis and the relationships between HIF-1alpha expression, VEGF expression and angiogenesis. Cirrhosis was induced in male Wistar rats by intraperitoneal administration of diethyl nitrosamine (DEN) (100 mg/kg, once a week). The serial sections from liver tissues were stained with anti-HIF-1alpha, anti-VEGF and anti-CD34 antibodies before being measured by light microscopy. Our results showed that HIF-1alpha expression gradually increases according to the severity of fibrosis (p<0.01). Moreover, its expression was found to be correlated with angiogenesis (r=0.916) and VEGF expression (r=0.969). The present study demonstrates that HIF-1alpha might have a role in the development of angiogenesis via regulation of VEGF during experimental liver fibrogenesis and suggests that this factor could be a potential target in the manipulation of angiogenesis in chronic inflammatory diseases of the liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614845     DOI: 10.1111/j.1600-0463.2007.apm_610.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

Review 1.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

2.  Development and characterization of a rat model of nonpenetrating liver trauma.

Authors:  Jennifer M Cox; John E Kalns
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

3.  HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways.

Authors:  Rui Lei; Jian Li; Feng Liu; Weihan Li; Shizhen Zhang; Yang Wang; Xi Chu; Jinghong Xu
Journal:  Cell Cycle       Date:  2019-10-23       Impact factor: 4.534

Review 4.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

5.  The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis.

Authors:  Masayoshi Yada; Masayuki Miyazaki; Kenta Motomura; Akihide Masumoto; Makoto Nakamuta; Motoyuki Kohjima; Rie Sugimoto; Yoshifusa Aratake; Nobuhiko Higashi; Shusuke Morizono; Shinichiro Takao; Naoki Yamashita; Takeaki Satoh; Shinsaku Yamashita; Masami Kuniyoshi; Kazuhiro Kotoh
Journal:  J Gastrointest Oncol       Date:  2016-08

6.  Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.

Authors:  Sumeet Virmani; Thomas K Rhee; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Laura M Kulik; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-10       Impact factor: 3.464

Review 7.  Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges.

Authors:  Jonathan Michael Harnoss; Moritz Johannes Strowitzki; Praveen Radhakrishnan; Lisa Katharina Platzer; Julian Camill Harnoss; Thomas Hank; Jun Cai; Alexis Ulrich; Martin Schneider
Journal:  Hypoxia (Auckl)       Date:  2015-01-30

8.  Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.

Authors:  A S Arboatti; F Lambertucci; M G Sedlmeier; G Pisani; J Monti; M de L Álvarez; D E A Francés; M T Ronco; C E Carnovale
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

9.  L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats.

Authors:  Derya Karabulut; Ali Tugrul Akin; Murat Unsal; Ayça Lekesizcan; Tuğçe Merve Ozyazgan; Didem Barlak Keti; Birkan Yakan; Görkem Ekebas
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

10.  Modulation of HIF-1α and STAT3 signaling contributes to anti-angiogenic effect of YC-1 in mice with liver fibrosis.

Authors:  Tzung-Yan Lee; Yann-Lii Leu; Chorng-Kai Wen
Journal:  Oncotarget       Date:  2017-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.